Compare DHR & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DHR | MCK |
|---|---|---|
| Founded | 1969 | 1833 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Other Pharmaceuticals |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.6B | 91.0B |
| IPO Year | 2007 | 1995 |
| Metric | DHR | MCK |
|---|---|---|
| Price | $176.70 | $771.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 14 |
| Target Price | $241.69 | ★ $952.92 |
| AVG Volume (30 Days) | ★ 3.5M | 855.5K |
| Earning Date | 04-21-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.89% | 0.40% |
| EPS Growth | N/A | ★ 49.22 |
| EPS | 1.45 | ★ 38.38 |
| Revenue | $19,893,000,000.00 | ★ $112,084,000,000.00 |
| Revenue This Year | $5.43 | $14.94 |
| Revenue Next Year | $5.74 | $8.21 |
| P/E Ratio | $122.32 | ★ $20.27 |
| Revenue Growth | ★ 8.53 | 3.11 |
| 52 Week Low | $160.93 | $637.00 |
| 52 Week High | $242.80 | $999.00 |
| Indicator | DHR | MCK |
|---|---|---|
| Relative Strength Index (RSI) | 46.04 | 48.16 |
| Support Level | $175.00 | $727.64 |
| Resistance Level | $198.50 | $779.31 |
| Average True Range (ATR) | 4.44 | 15.47 |
| MACD | -0.27 | 4.24 |
| Stochastic Oscillator | 18.93 | 59.77 |
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.